References

Immortal time bias in observational studies of time-to-event outcomes: assessing effects of postmastectomy radiation therapy using the national cancer database

2018 · External reference

Why summary comorbidity measures such as the Charlson comorbidity Index and elixhauser score work

10.1097/mlr.0b013e318297429c · 2015 · External reference

ATIM-14. Alliance A071101: a phase II randomized trial comparing the efficacy of heat shock protein peptide COMPLEX-96 (HSPPC-96) vaccine given with bevacizumab versus bevacizumab alone in the treatment of surgically resectable recurrent glioblastoma

2017 · External reference

Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study

10.1186/s13058-017-0928-0 · 2018 · External reference

Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the Mayo clinic experience

10.1097/coc.0b013e3181e8461a · 2011 · External reference

Escitalopram oxalate induces apoptosis in U-87MG cells and autophagy in GBM8401 cells

10.1111/jcmm.13372 · 2018 · External reference

Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: correlations with clinical data

10.3233/cbm-130310 · 2014 · External reference

Statistical methods for elimination of guarantee-time bias in cohort studies: a simulation study

10.1186/s12874-017-0405-6 · 2017 · External reference

Unresolved reference

External reference

The risk of being depressed is significantly higher in cancer patients than in the general population: prevalence and severity of depressive symptoms across major cancer types

10.1016/j.ejca.2016.11.017 · 2017 · External reference

MGMT gene silencing and benefit from temozolomide in glioblastoma

10.1056/nejmoa043331 · 2005 · External reference

Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting

10.1007/s11060-016-2280-0 · 2017 · External reference

Correlation of psychooncological distress- screening and quality of life assessment in neurosurgical patients

10.18632/oncotarget.22802 · 2017 · External reference

Association between depression and brain tumor: a systematic review and meta-analysis

10.18632/oncotarget.19843 · 2017 · External reference

Moving beyond Karnofsky and ECOG performance status assessments with new technologies

2016 · External reference

Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice

10.1080/2162402x.2017.1405205 · 2018 · External reference

Improved survival time trends for glioblastoma using the SEER 17 population-based registries

10.1007/s11060-011-0738-7 · 2012 · External reference

Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments

10.1002/pon.3409 · 2014 · External reference

Ido1 inhibition synergizes with radiation and PD-1 blockade to durably increase survival against advanced glioblastoma

10.1158/1078-0432.ccr-17-3573 · 2018 · External reference

Primary brain tumor patients’ supportive care needs and multidisciplinary rehabilitation, community and psychosocial support services: awareness, referral and utilization

10.1007/s11060-015-2013-9 · 2016 · External reference

Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis

10.18632/oncotarget.3243 · 2015 · External reference

Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis

10.1186/s12885-018-3990-9 · 2018 · External reference

The role of inflammation in depression: from evolutionary imperative to modern treatment target

2016 · External reference

Use of non-selective beta-blockers is associated with decreased tumor proliferative indices in early stage breast cancer

10.18632/oncotarget.14119 · 2017 · External reference

Beta-adrenergic signaling impairs antitumor CD8(+) T-cell responses to B-cell lymphoma immunotherapy

10.1158/2326-6066.cir-17-0401 · 2018 · External reference

Antidepressants for the treatment of depression in people with cancer

2018 · External reference

The interplay among psychological distress, the immune system, and brain tumor patient outcomes

10.1016/j.cobeha.2019.01.009 · 2019 · External reference

European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma

10.1016/s1470-2045(17)30345-5 · 2017 · External reference

Psychosocial stress and inflammation in cancer

10.1016/j.bbi.2012.06.015 · 2013 · External reference

Adrenergic signaling: a targetable checkpoint limiting development of the antitumor immune response

10.3389/fimmu.2018.00164 · 2018 · External reference

Randomized phase 3 study evaluating the efficacy and safety of nivolumab vs bevacizumab in patients with recurrent glioblastoma: CheckMate 143

2017 · External reference

Induction of suppressor cells and increased tumor growth following chronic psychosocial stress in male mice

10.1371/journal.pone.0159059 · 2016 · External reference

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

10.1093/neuonc/nou348 · 2015 · External reference

Depression and survival of glioma patients: a systematic review and meta-analysis

10.1016/j.clineuro.2018.06.016 · 2018 · External reference

IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma

10.1111/j.1349-7006.2011.02134.x · 2012 · External reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

10.1056/nejmoa043330 · 2005 · External reference

Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial

10.1001/jama.2017.18718 · 2017 · External reference

Immortal time bias in pharmaco-epidemiology

10.1093/aje/kwm324 · 2008 · External reference

Drug repositioning in glioblastoma: a pathway perspective

10.3389/fphar.2018.00218 · 2018 · External reference

Unresolved reference

2013 · External reference

Unresolved reference

2018 · External reference

Antidepressants, sertraline and paroxetine, increase calcium influx and induce mitochondrial damage-mediated apoptosis of astrocytes

10.18632/oncotarget.23302 · 2017 · External reference

Impact of gender on the survival of patients with glioblastoma

10.1042/bsr20180752 · 2018 · External reference

Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells

2018 · External reference

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

10.1016/s1470-2045(17)30517-x · 2017 · External reference

Ipw: an R package for inverse probability weighting

2011 · External reference

Interleukins in glioblastoma pathophysiology: implications for therapy

10.1111/bph.12008 · 2013 · External reference